Zurcher Kantonalbank Zurich Cantonalbank Has $33.43 Million Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Zurcher Kantonalbank Zurich Cantonalbank increased its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 11.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 56,252 shares of the biotechnology company’s stock after purchasing an additional 5,760 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank owned approximately 0.07% of Axon Enterprise worth $33,432,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Prestige Wealth Management Group LLC boosted its stake in Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 44 shares during the period. New Wave Wealth Advisors LLC acquired a new position in shares of Axon Enterprise during the 4th quarter worth about $40,000. Brooklyn Investment Group acquired a new position in shares of Axon Enterprise during the 3rd quarter worth about $41,000. Y.D. More Investments Ltd acquired a new position in shares of Axon Enterprise during the 4th quarter worth about $45,000. Finally, Planning Capital Management Corp boosted its stake in shares of Axon Enterprise by 83.3% during the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after buying an additional 55 shares during the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Axon Enterprise

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Michael Garnreiter sold 1,000 shares of the firm’s stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $639.69, for a total transaction of $639,690.00. Following the transaction, the director now directly owns 24,259 shares in the company, valued at $15,518,239.71. This represents a 3.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 5,146 shares of company stock valued at $3,262,847 in the last three months. 6.10% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on AXON shares. Robert W. Baird increased their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. The Goldman Sachs Group increased their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. Craig Hallum downgraded shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a research note on Monday. Northcoast Research downgraded shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $600.00 target price on shares of Axon Enterprise in a report on Wednesday, February 26th. One analyst has rated the stock with a sell rating, three have issued a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $587.38.

Axon Enterprise Stock Down 2.1 %

Axon Enterprise stock opened at $515.45 on Tuesday. The stock has a market cap of $39.50 billion, a P/E ratio of 133.19, a P/E/G ratio of 5.17 and a beta of 1.12. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99. The company’s 50-day moving average price is $597.64 and its two-hundred day moving average price is $531.62.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.